Immunoprecise Antibodies
Quarterly Financials
| Values in thousands | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 |
|---|---|---|---|---|
Revenue | $5,263 | $6,459 | $6,150 | $6,150 |
Gross Profit | 2,356 | 3,108 | 2,954 | 2,954 |
EBITDA | -3,232 | -2,273 | -1,441 | -1,441 |
EBIT | -4,627 | -3,852 | -2,794 | -2,794 |
Net Income | -3,999 | -18,045 | -2,622 | -2,622 |
Net Change In Cash | 5,263 | 6,459 | 6,150 | 6,150 |
Free Cash Flow | -2,087 | -3,770 | -534 | -534 |
Cash | 3,913 | 3,459 | 6,017 | 6,017 |
Basic Shares | 25,600 | 26,944 | 25,050 | 25,050 |
Annual Financials
| Values in thousands | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|
Revenue | $24,518 | $20,665 | $19,364 | $17,912 |
Gross Profit | 12,053 | 11,563 | 10,983 | 11,538 |
EBITDA | -8,004 | -21,264 | -12,122 | -181 |
EBIT | -13,739 | -27,949 | -15,891 | -3,894 |
Net Income | -27,177 | -26,560 | -16,709 | -7,340 |
Net Change In Cash | 24,518 | 20,665 | 19,364 | 17,912 |
Free Cash Flow | -5,643 | -21,328 | -11,178 | -2,027 |
Cash | 3,459 | 8,280 | 29,965 | 41,759 |
Basic Shares | 25,635 | 24,897 | 19,688 | 16,474 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-07-31 | -$0.11 |
2024-04-30 | -$0.11 |
2024-01-31 | -$0.11 |
2023-10-31 | -$0.10 |
